Singh Avani M, Zhang Hailing, Sokol Lubomir
Hematology and Medical Oncology, University of South Florida, Tampa, USA.
Hematology and Medical Oncology, Moffitt Cancer Center, Tampa, USA.
Cureus. 2023 Jan 3;15(1):e33297. doi: 10.7759/cureus.33297. eCollection 2023 Jan.
Olfactory neuroblastoma is a rare disease with no randomized clinical trials to guide treatment decision making. Surgery, radiation, and chemotherapy are all used for treatment, and prognosis is mostly determined by the histologic grade and clinical stage. While a neuroendocrine type of neoplasm is similar to small cell carcinoma, metastatic disease in olfactory neuroblastoma is rare. We present a case at our institution of an uncommon clinical course of relapsed olfactory neuroblastoma complicated by severe thrombocytopenia.
嗅神经母细胞瘤是一种罕见疾病,尚无随机临床试验来指导治疗决策。手术、放疗和化疗均用于治疗,预后大多取决于组织学分级和临床分期。虽然神经内分泌型肿瘤与小细胞癌相似,但嗅神经母细胞瘤的转移性疾病很少见。我们报告了我院一例复发性嗅神经母细胞瘤并发严重血小板减少症的不寻常临床病程病例。